Evidence map›Paper›PMID 22465060›Full record

ReviewPharmacology & therapeutics2012

Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

A V Terry

Abstract readReview
In one paragraph

Review in Pharmacology & therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 239 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

A V TerryDepartment of Pharmacology and Toxicology, Georgia Health Sciences University, Augusta, GA 30912, USA. aterry@georgiahealth.edu
Augusta University Health · US

Funding

Cholinesterase Inhibitors, Axonal Transport, and MemoryR01ES012241 · NIEHS · UNIVERSITY OF GEORGIA (UGA) · PI TERRY, ALVIN V · 2004 to 2013
$2.8M
Drug Discovery for Cognitive Impairment Associated with Drugs of AbuseR01DA029127 · NIDA · AUGUSTA UNIVERSITY · PI TERRY, ALVIN V · 2010 to 2014
$1.7M
Cotinine for Cognitive Impairment in Neurological and Neuropsychiatric DisordersR01AG029617 · NIA · AUGUSTA UNIVERSITY · PI TERRY, ALVIN V · 2007 to 2010
$1.2M
NIA NIH HHS AG029617NIA NIH HHS R01 AG029617NIDA NIH HHS DA029127NIDA NIH HHS R01 DA029127NIEHS NIH HHS ES012241NIEHS NIH HHS R01 ES012241
6 · The paper itself

Abstract

The class of chemicals known as the "organophosphates" (OPs) comprises many of the most common agricultural and commercial pesticides that are used worldwide as well as the highly toxic chemical warfare agents. The mechanism of the acute toxicity of OPs in both target and non-target organisms is primarily attributed to inhibitory actions on various forms of cholinesterase leading to excessive peripheral and central cholinergic activity. However, there is now substantial evidence that this canonical (cholinesterase-based) mechanism cannot alone account for the wide-variety of adverse consequences of OP exposure that have been described, especially those associated with repeated exposures to levels that produce no overt signs of acute toxicity. This type of exposure has been associated with prolonged impairments in attention, memory, and other domains of cognition, as well as chronic illnesses where these symptoms are manifested (e.g., Gulf War Illness, Alzheimer's disease). Due to their highly reactive nature, it is not surprising that OPs might alter the function of a number of enzymes and proteins (in addition to cholinesterase). However, the wide variety of long-term neuropsychiatric symptoms that have been associated with OPs suggests that some basic or fundamental neuronal process was adversely affected during the exposure period. The purpose of this review is to discuss several non-cholinesterase targets of OPs that might affect such fundamental processes and includes cytoskeletal and motor proteins involved in axonal transport, neurotrophins and their receptors, and mitochondria (especially their morphology and movement in axons). Potential therapeutic implications of these OP interactions are also discussed.

Indexed as

AnimalsAxonal TransportChemical Warfare AgentsCognition DisordersHumansInsecticidesMitochondriaModels, NeurologicalNerve Growth FactorsNeuronsOrganophosphatesOxidative StressPersian Gulf SyndromeChemical Warfare AgentsInsecticidesNerve Growth FactorsOrganophosphates

Identifiers

PMID22465060
PMCPMC3366364
OpenAlexW1963754411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.